| Dr Davena Marie Norris, PHARMD, RPH, PHC | |
|
2450 S Telshor Blvd, Las Cruces, NM 88011-5141 | |
| (575) 521-5370 | |
| (575) 521-5376 |
| Full Name | Dr Davena Marie Norris |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 2450 S Telshor Blvd, Las Cruces, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063708261 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Davena Marie Norris, PHARMD, RPH, PHC 612 W. Hadley Ave, Las Cruces, NM 88005-5141 Ph: (575) 636-7326 | Dr Davena Marie Norris, PHARMD, RPH, PHC 2450 S Telshor Blvd, Las Cruces, NM 88011-5141 Ph: (575) 521-5370 |
News Archive
Inflammation plays a key role in improving the ability to relearn motor skills lost as a result of spinal cord injuries, such as grasping objects, new University of Alberta research shows.
Researchers at the University of Chicago Medicine and the University of Illinois at Chicago (UIC) are launching an investigational study to determine the effects of increased education and access to rapid, FDA-approved COVID-19 testing on community perceptions, access, and use of COVID-19 testing resources.
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
Plexxikon today announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 in patients with previously untreated metastatic melanoma with the BRAF mutation. Patients treated with PLX4032 had an improved overall survival compared to patients treated with dacarbazine, the current standard of care.
In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma.
› Verified 4 days ago
Mrs. Renee Allison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3331 Rinconada Blvd, Las Cruces, NM 88011 Phone: 575-680-3779 | |
Dale Menges, RPHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Thorpe Rd, Las Cruces, NM 88012 Phone: 505-382-6812 | |
Lynda Caroline Ralston, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1256 El Paseo Rd, Las Cruces, NM 88001 Phone: 575-525-8713 Fax: 575-541-8561 | |
Min Bae, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Bataan Memorial E # Lc, Las Cruces, NM 88011 Phone: 575-522-8603 | |
Dr. Jennifer Morales, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3490 Northrise Dr, Las Cruces, NM 88011 Phone: 575-382-9100 | |
Wesley Dixon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Thorpe Rd, Las Cruces, NM 88012 Phone: 505-382-6812 | |
Eva Kamianowski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3490 Northrise Dr, Las Cruces, NM 88011 Phone: 575-382-9100 |